Toxoplasmosis Parasite (Toxoplasma Gondii) U.S Food and Drug Adminstration (FDA) have successfully done the first test of infection with Toxoplasmosis Parasite (Toxoplasma Gondii) to find out whether a person or a pregnant woman is having swollen lymph nodes tests are positive for toxoplasmosis parasite (Toxoplasma Gondii) which…

BD Diagnostics of BD (Becton, Dickinson and Company) launches its BD Max™ open system for molecular testing in Europe for laboratories and clinicians to run BD developed assays so that they can provide enhanced testing services that recognize them as standard caring institution.  

The BD Max™ system is the fully-automated molecular testing for molecular diagnostics system also called as The next Generation Molecular Platform. This provides the handy and on demand workflow with system which fully automates Nucleic acid extraction, Cell analysis, PCR setup, Detection and Amplification.

The U.S Food and Drug Administration makes announcement that it will introduce the steps which will reduce the risk for spreading of disease through reusable surgical and medical devices. This risk becomes more exposed if these were not properly sterilized.

B.D (Becton, Dickinson and Company) and Waste Management Healthcare Solutions (WMHS) announced BD ecoFinity™ service, a joint venture agreement for recycling the medical and hospital waste and from other healthcare facilities in US.

BD Diagnostics anoounced that they received clearance form FDA for its First Fully Automated Molecular Assays for HSV1 and HSV2. After this clinicians now have a tool to help diagnose patients with Herpes Simplex Viruses (HSV1 and HSV2).

Radiation safety is now become an important issue in the world after the nuclear disaster in Japan. This earthquake after effects left Radiation safety question in our mind. So far radiation in 13 states have not crossed its limits in United States, but we all…

Becton,Dickinson and company,BD and UCL business announced an agreement for improving the early detection system for breast cancers and ovarian cancers so that early and effective treatment can be provided to the patients.